Presentation is loading. Please wait.

Presentation is loading. Please wait.

Antagonizing ClpP: A New Power Play in Targeted Therapy for AML

Similar presentations


Presentation on theme: "Antagonizing ClpP: A New Power Play in Targeted Therapy for AML"— Presentation transcript:

1 Antagonizing ClpP: A New Power Play in Targeted Therapy for AML
Karilyn Larkin, John C. Byrd  Cancer Cell  Volume 27, Issue 6, Pages (June 2015) DOI: /j.ccell Copyright © 2015 Elsevier Inc. Terms and Conditions

2 Figure 1 ClpP’s Proposed Role in Oxidative Phosphorylation
(A) ClpP is a nuclear encoded serine protease that is translated in the cytoplasm and then trafficked into the mitochondria, where it is assembled into tetradecamers with its chaperone protein ClpX. (B) Based on protein interaction assays, ClpP associates with members of the electron transport chain, specifically succinate dehydrogenase subunit A (SDHA), and other enzymes inherent to metabolism. Cole et al. (2015) hypothesized that ClpP plays an analogous role to cytosolic proteasomes and degrades dysfunctional proteins within the mitochondria. Cancer Cell  , DOI: ( /j.ccell ) Copyright © 2015 Elsevier Inc. Terms and Conditions


Download ppt "Antagonizing ClpP: A New Power Play in Targeted Therapy for AML"

Similar presentations


Ads by Google